Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 705 clinical trials
Featured trial
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

  • 102 views
  • 08 Nov, 2020
  • 1 location
Featured trial
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

  • 552 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

  • 317 views
  • 25 Mar, 2021
  • 4 locations
Featured trial
Do you suffer from Hemorrhoids?

Do you suffer from Hemorrhoids?

  • 1320 views
  • 25 Mar, 2021
  • 1 location
None
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Individuals receiving dialysis are at risk of heart failure and heart related death. There is an urgent need for treatments that reduce the risk of these problems in patients that require dialysis. Spironolactone is a pill used to prevent heart failure and related deaths in patients that do not require …

  • 59 views
  • 26 Jan, 2021
  • 98 locations
None
Survey and Reduction of Mortality in Peridialysis Uremic Patients Via Intervention of Risk Factors

In patients with non-dialysis-dependent end stage kidney disease (ESKD) the common transition of care to renal replacement therapy is dialysis. Each year over 70 000 Chinese transition from non

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Fufang E'Jiao Jiang Intervening Cancer-related Fatigue

With the therapeutic tool of carcinoma increasing, life span extending, the solicitude for the patients'quality of life appear more important. Cancer-related fatigue (CRF) is one of the most

  • 1 views
  • 24 Jan, 2021
  • 1 location
None
Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease: a Randomized Comparison Trial

thrombosis or Pulmonary thromboembolism, 4. Percutaneous trans-luminal angioplasty on peripheral artery obstructive disease, 5. Aortic intervention or operation, 6. ESRD with renal replacement therapy).

  • 12 views
  • 22 Jan, 2021
None
Twice Against Thrice-weekly Hemodialysis

Hemodialysis is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. The frequency of sessions per week remains a debatable issue. In the majority

chronic hemodialysis
hypertension
chronic renal failure
renal replacement therapy
  • 23 views
  • 05 Oct, 2021
  • 1 location
None
Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)

Recent endovascular thrombectomy (EVT) trial have proven the effectiveness of intraarterial revascularization in patients with larger cerebral artery occlusion. The success rate of EVT is close to 80%, but only 50% of patients improve to independent functional outcome. Therefore, new treatment strategies are needed to reduce the futile revascularization. However, …

arterial occlusion
thrombectomy
ischemia
stroke
cerebral infarction
  • 0 views
  • 22 Aug, 2021
  • 1 location